Peter Blume-Jensen - 09 Nov 2022 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
President and CEO, Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
09 Nov 2022
Net transactions value
$0
Form type
3
Filing time
09 Nov 2022, 19:30:31 UTC
Next filing
16 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACRV Common Stock 871,857 09 Nov 2022 Direct
holding ACRV Common Stock 293,998 09 Nov 2022 See footnote. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACRV Stock Option (Right to Buy) 09 Nov 2022 Common Stock 165,947 $1.04 Direct F2
holding ACRV Stock Option (Right to Buy) 09 Nov 2022 Common Stock 124,460 $3.88 Direct F3
holding ACRV Stock Option (Right to Buy) 09 Nov 2022 Common Stock 82,973 $1.04 See footnote. F1, F2
holding ACRV Stock Option (Right to Buy) 09 Nov 2022 Common Stock 62,230 $3.88 See footnote. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2 Twenty-five percent (25%) of the shares subject to the option vested on October 5, 2020, and the remaining shares subject to the option vested or shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
F3 The shares subject to the option vested or shall vest quarterly on the last day of each quarter for 16 quarters following January 1, 2022, in each case subject to the Reporting Person's continuous service through each such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney